Non Hodgkin Lymphoma Incidence and Mortality by Year, Black Individuals, New York State Excl New York City, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 29 7.7 4.9-11.5 17 9.6 5.3-16.1 12 6.0 2.8-10.9 12 4.7 2.2-8.4 6 5.4 1.6-12.5 6 4.0 1.3-8.8
1977 46 12.2 8.7-16.7 28 17.7 11.1-26.7 18 8.3 4.7-13.4 24 6.9 4.2-10.7 14 10.8 5.0-19.6 10 4.6 2.1-8.6
1978 47 12.1 8.6-16.6 24 12.0 7.5-18.4 23 11.6 7.0-17.9 13 3.3 1.6-5.9 8 4.0 1.7-8.5 5 2.6 0.7-6.3
1979 30 6.5 4.2-9.5 16 6.3 3.5-10.9 14 6.3 3.3-10.7 29 7.7 4.8-11.5 18 8.3 4.8-13.7 11 6.4 3.0-11.7
1980 26 6.9 4.2-10.5 16 11.0 5.3-19.5 10 4.5 2.1-8.5 18 5.1 2.8-8.2 8 5.9 2.0-12.6 10 4.8 2.2-9.0
1981 32 8.0 5.2-11.6 20 9.6 5.5-15.7 12 6.3 3.1-11.1 18 4.1 2.3-6.7 8 4.7 1.7-10.0 10 3.9 1.8-7.2
1982 35 7.6 5.2-10.7 24 12.3 7.5-19.0 11 4.1 2.0-7.5 8 1.6 0.7-3.3 6 3.0 1.1-6.9 2 0.6 0.1-2.5
1983 41 8.5 6.0-11.8 23 9.2 5.7-14.3 18 7.4 4.3-11.9 18 3.8 2.2-6.1 10 4.0 1.9-7.8 8 3.4 1.4-6.7
1984 41 8.6 6.0-12.0 24 9.7 6.0-15.0 17 7.3 4.1-11.7 35 7.9 5.4-11.2 20 9.1 5.4-14.4 15 6.5 3.5-10.9
1985 47 9.5 6.8-12.8 28 13.4 8.3-20.3 19 6.8 4.0-10.7 25 5.4 3.5-8.1 14 6.6 3.5-11.4 11 4.5 2.2-8.0
1986 51 10.2 7.4-13.7 25 10.5 6.2-16.4 26 9.7 6.2-14.4 20 4.1 2.4-6.4 12 5.3 2.6-9.8 8 2.9 1.2-5.9
1987 50 9.2 6.7-12.2 29 11.9 7.6-17.8 21 7.0 4.3-10.8 18 4.1 2.3-6.5 12 5.9 2.8-10.8 6 2.6 0.9-5.5
1988 57 10.9 8.0-14.3 35 15.8 10.2-23.1 22 7.5 4.6-11.5 32 7.2 4.7-10.4 21 13.1 7.3-21.0 11 3.8 1.8-7.0
1989 69 11.0 8.5-14.1 37 12.3 8.3-17.5 32 10.0 6.8-14.1 28 5.1 3.3-7.6 16 6.2 3.3-10.7 12 4.2 2.1-7.3
1990 79 14.0 10.9-17.7 46 15.9 11.3-21.9 33 11.5 7.8-16.3 31 5.7 3.8-8.1 16 6.7 3.6-11.3 15 4.9 2.7-8.2
1991 74 11.9 9.1-15.3 45 14.8 10.0-21.1 29 9.4 6.2-13.7 34 6.2 4.2-8.9 19 6.8 4.0-11.0 15 5.3 2.9-8.7
1992 77 12.5 9.7-15.9 55 19.2 13.9-25.7 22 7.0 4.3-10.7 29 5.6 3.6-8.1 19 8.4 4.7-13.5 10 3.5 1.6-6.4
1993 94 14.4 11.5-17.8 57 19.2 14.2-25.5 37 10.4 7.3-14.5 39 7.0 4.9-9.7 16 5.2 2.8-8.8 23 7.8 4.9-11.7
1994 86 13.1 10.4-16.4 47 14.8 10.6-20.2 39 11.4 8.0-15.6 28 5.4 3.5-7.8 19 8.3 4.6-13.6 9 3.2 1.4-6.0
1995 101 14.8 11.9-18.2 71 23.8 17.7-31.1 30 8.1 5.4-11.7 33 5.9 4.0-8.4 16 4.9 2.8-8.2 17 5.8 3.3-9.2
1996 116 17.0 13.9-20.6 70 20.1 15.4-25.9 46 13.3 9.6-17.8 32 5.5 3.7-7.9 19 7.9 4.3-13.0 13 4.0 2.1-6.8
1997 102 14.7 11.8-18.0 61 20.3 14.9-26.9 41 10.8 7.7-14.7 21 3.7 2.2-5.8 11 5.3 2.4-9.8 10 3.0 1.4-5.4
1998 118 16.3 13.4-19.6 73 22.5 17.1-29.0 45 11.6 8.4-15.5 34 5.4 3.7-7.6 20 7.6 4.3-12.2 14 4.0 2.2-6.7
1999 129 17.9 14.8-21.4 74 22.2 17.0-28.4 55 14.1 10.6-18.5 32 5.0 3.4-7.2 15 4.7 2.5-8.0 17 4.9 2.8-7.9
2000 101 13.0 10.5-15.9 55 16.1 11.8-21.4 46 10.9 7.9-14.6 42 6.1 4.4-8.4 31 10.6 6.8-15.5 11 2.9 1.5-5.2
2001 124 16.1 13.2-19.3 74 20.1 15.5-25.6 50 12.2 9.0-16.1 42 6.6 4.7-9.0 21 8.5 5.0-13.2 21 5.5 3.4-8.4
2002 129 16.3 13.5-19.5 74 20.2 15.6-25.8 55 13.0 9.7-16.9 48 6.6 4.8-8.9 26 7.7 4.9-11.6 22 5.5 3.4-8.4
2003 122 15.6 12.9-18.8 56 16.3 12.0-21.5 66 15.4 11.9-19.7 27 3.8 2.4-5.5 14 4.1 2.1-7.0 13 3.3 1.7-5.6
2004 112 14.3 11.7-17.4 63 19.3 14.2-25.4 49 11.2 8.2-14.9 36 5.2 3.6-7.3 19 5.8 3.3-9.4 17 4.5 2.6-7.1
2005 118 14.7 12.1-17.7 68 18.8 14.2-24.3 50 11.6 8.5-15.3 32 4.7 3.2-6.7 18 6.6 3.7-10.6 14 3.5 1.9-5.8
2006 140 16.6 13.9-19.7 75 19.7 15.2-25.1 65 14.1 10.8-18.0 34 4.2 2.9-5.9 19 4.8 2.8-7.8 15 3.5 2.0-5.8
2007 128 14.8 12.2-17.6 76 20.9 16.1-26.6 52 10.7 7.9-14.0 31 3.9 2.6-5.6 19 6.0 3.4-9.7 12 2.7 1.4-4.7
2008 161 17.9 15.2-21.0 96 24.3 19.4-30.1 65 13.2 10.1-16.8 32 3.8 2.6-5.5 21 6.3 3.7-9.8 11 2.2 1.1-4.0
2009 136 15.0 12.5-17.8 69 17.3 13.2-22.2 67 13.4 10.3-17.0 34 3.8 2.6-5.4 23 6.1 3.7-9.4 11 2.2 1.1-4.0
2010 144 15.5 13.0-18.4 78 18.1 14.1-22.9 66 13.1 10.1-16.8 42 5.0 3.6-6.8 22 5.9 3.6-9.2 20 4.4 2.7-6.8
2011 162 17.2 14.5-20.1 103 25.2 20.2-31.1 59 11.4 8.6-14.7 42 5.0 3.6-6.8 27 7.6 4.8-11.3 15 3.2 1.7-5.2
2012 142 14.4 12.1-17.1 74 16.9 13.1-21.5 68 12.4 9.6-15.8 33 3.7 2.5-5.3 16 4.8 2.6-7.9 17 3.2 1.8-5.1
2013 147 15.1 12.7-17.8 78 18.2 14.2-23.0 69 12.7 9.8-16.1 28 3.2 2.1-4.7 14 3.3 1.7-5.7 14 2.9 1.6-4.8
2014 154 15.2 12.9-17.9 89 20.1 15.9-25.0 65 11.5 8.9-14.8 43 4.9 3.5-6.6 25 7.3 4.6-10.8 18 3.4 2.0-5.4
2015 180 17.1 14.6-19.8 86 18.6 14.6-23.2 94 16.3 13.1-20.0 39 3.9 2.8-5.4 21 4.9 2.9-7.7 18 3.1 1.8-5.0
2016 174 16.5 14.1-19.3 92 19.9 15.8-24.6 82 14.0 11.1-17.4 36 3.7 2.6-5.1 21 5.5 3.3-8.5 15 2.5 1.4-4.1
2017 173 16.1 13.8-18.8 94 20.2 16.1-24.9 79 13.2 10.4-16.5 49 4.7 3.4-6.2 34 7.6 5.1-10.8 15 2.6 1.5-4.4
2018 166 15.0 12.8-17.6 93 18.9 15.0-23.3 73 12.2 9.5-15.4 37 3.2 2.2-4.4 21 4.0 2.4-6.2 16 2.6 1.5-4.3
2019 191 16.7 14.4-19.3 113 21.9 17.8-26.5 78 12.4 9.7-15.5 47 4.4 3.2-5.9 28 6.6 4.3-9.6 19 3.1 1.8-4.8
2020 153 13.3 11.3-15.7 79 15.5 12.1-19.5 74 11.8 9.2-14.8 41 3.6 2.6-4.9 20 3.7 2.2-5.9 21 3.3 2.0-5.1

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.